Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Making progress on progression in metastatic prostate cancer.

Publication ,  Journal Article
Armstrong, AJ; Halabi, S
Published in: J Clin Oncol
April 20, 2015

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Clin Oncol

DOI

EISSN

1527-7755

Publication Date

April 20, 2015

Volume

33

Issue

12

Start / End Page

1322 / 1324

Location

United States

Related Subject Headings

  • Radiography
  • Prostatic Neoplasms, Castration-Resistant
  • Oncology & Carcinogenesis
  • Neoplastic Cells, Circulating
  • Male
  • Humans
  • Biomarkers, Tumor
  • Antineoplastic Combined Chemotherapy Protocols
  • Androstenes
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Armstrong, A. J., & Halabi, S. (2015). Making progress on progression in metastatic prostate cancer. J Clin Oncol, 33(12), 1322–1324. https://doi.org/10.1200/JCO.2014.59.4283
Armstrong, Andrew J., and Susan Halabi. “Making progress on progression in metastatic prostate cancer.J Clin Oncol 33, no. 12 (April 20, 2015): 1322–24. https://doi.org/10.1200/JCO.2014.59.4283.
Armstrong AJ, Halabi S. Making progress on progression in metastatic prostate cancer. J Clin Oncol. 2015 Apr 20;33(12):1322–4.
Armstrong, Andrew J., and Susan Halabi. “Making progress on progression in metastatic prostate cancer.J Clin Oncol, vol. 33, no. 12, Apr. 2015, pp. 1322–24. Pubmed, doi:10.1200/JCO.2014.59.4283.
Armstrong AJ, Halabi S. Making progress on progression in metastatic prostate cancer. J Clin Oncol. 2015 Apr 20;33(12):1322–1324.

Published In

J Clin Oncol

DOI

EISSN

1527-7755

Publication Date

April 20, 2015

Volume

33

Issue

12

Start / End Page

1322 / 1324

Location

United States

Related Subject Headings

  • Radiography
  • Prostatic Neoplasms, Castration-Resistant
  • Oncology & Carcinogenesis
  • Neoplastic Cells, Circulating
  • Male
  • Humans
  • Biomarkers, Tumor
  • Antineoplastic Combined Chemotherapy Protocols
  • Androstenes
  • 3211 Oncology and carcinogenesis